Lupus is three times more common in Black and Hispanic/Latina American women than in white women.
Due to the mistrust of the healthcare system, Black and Hispanic/Latino Americans are less likely to participate in clinical trials.
They are also often excluded from clinical trials that study lupus treatment. With lower participation rates, Black and Hispanic/Latino people miss out on emerging treatment opportunities.
The voices of people of color are needed now more than ever to advance science. We need diverse voices to help shape lupus outcomes for all.
People of color are more likely to face premature death as a result of lupus complications.
Without clinical trial participation, the experience of Black and Hispanic/Latina women won’t be considered when it comes to lupus therapies and medication.
That is why we need more women of color to sign up for clinical trials … today!
Clinical Trial Locator Resources
Community Health Assessment Resources